Glutamine potentiates cefoperazone-sulbactam activity against Pseudomonas aeruginosa by increasing membrane permeability and cellular uptake

Glutamine potentiates cefoperazone-sulbactam activity against Pseudomonas aeruginosa by increasing membrane permeability and cellular uptake

PurposesThe combination of an antibiotic with a metabolic reprogramming agent is anticipated to emerge as a promising therapeutic strategy against antibiotic-resistant bacteria, though this hypothesis requires validation through preclinical pharmacodynamic studies.MethodsThis study evaluated the pre...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jiao Xiang, Xin Wang, Huiyin Lin, Lifen Yang, Xiaoxia Huang, Yuetao Chen, Yingyue Zeng, Shaohua Li, Xianliang Zhao, Shiwen Wang, Yuan Tao, Huanzhe Fu, Zhengqi Shi, Kuihai Wu, Xuanxian Peng, Hui Li, Jin Tang, Zhuanggui Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Microbiology
Subjects:	preclinical pharmacodynamics cefoperazone/sulbactam multidrug resistance carbapenem resistance glutamine Pseudomonas aeruginosa
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2025.1631646/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of cefoperazone-sulbactam as a component of combination therapy for carbapenem-resistant Acinetobacter baumannii bloodstream infection in intensive care units: a multicenter retrospective propensity score-matched study
by: Sheng-Huei Wang, et al.
Published: (2025-07-01)

Role of the gut microbiota in cefoperazone/sulbactam-induced epilepsy in mice with chronic renal failure
by: Yulu Wu, et al.
Published: (2024-12-01)

Clinical efficacy of ambroxol combined with cefoperazone sodium and sulbactam sodium in the treatment of senile severe pneumonia
by: Lu Qiuying, et al.
Published: (2025-05-01)

Spectrophotometric method development and validation for simultaneous quantification of Cefoperazone and Sulbactum sodium in bulk and marketed formulation: greenness profile evaluation
by: Nitin Kumar, et al.
Published: (2025-06-01)

Cefepime/Sulbactam — A New Innovative Antibiotic for In-Hospital Treatment of Severe Infections and the Implementation of Carbapenem-Replacement Strategy to Contain Antibiotic Resistance
by: S. V. Yakovlev, et al.
Published: (2021-06-01)

Cefotaxime/Sulbactam: an Important Addition to the Arsenal of Inhibitor-Protected Beta-Lactam Antibiotics
by: S. V. Yakovlev, et al.
Published: (2020-05-01)

<i>Acinetobacter baumannii</i>: Mechanisms of Antimicrobial Resistance
by: N. E. Barantsevich, et al.
Published: (2025-04-01)

Evaluation of the efficacy of sulbactam combination therapy for monomicrobial and polymicrobial pulmonary infections caused by multidrug-resistant Acinetobacter baumannii
by: Liangfei Peng, et al.
Published: (2025-06-01)

Treatment Approaches for Bronchopulmonary Infection in Myasthenia Gravis Patients
by: V. I. Sokolova, et al.
Published: (2020-05-01)

On the use of glutamine-containing specialty foods in sports
by: A. V. Slivin, et al.
Published: (2022-05-01)

Targeting glutamine metabolism as a potential target for cancer treatment
by: Wenxuan Zou, et al.
Published: (2025-07-01)

<i>In vitro</i> activity of cefepime / sulbactam and biapenem against Enterobacterales and <i>Pseudomonas aeruginosa</i> isolated from blood culture from patients with hematological diseases: results of a multicenter study
by: G. A. Klyasova, et al.
Published: (2023-05-01)

Development of criteria for interpretation and quality assessment of the results of susceptibility testing of Enterobacterales and Pseudomonas aeruginosa to cefepime-sulbactam
by: Edelstein M.V., et al.
Published: (2024-12-01)

Protective effects of L-glutamine against toxicity of&nbsp;deltamethrin in the cerebral tissue
by: Varol S, et al.
Published: (2016-04-01)

Characterization of glutamine synthetase involved in the fecundity of Rhopalosiphum padi
by: Xing-Ye Li, et al.
Published: (2025-07-01)

Effects of Glutamine Supplementation and Early Cold Conditioning on Cold Stress Adaptability in Broilers
by: Hanan Al-Khalaifah, et al.
Published: (2025-05-01)

GPT2 mediates glutamine metabolism-driven metabolic alterations in platinum-resistant ovarian cancer cells
by: Adriana Ponton-Almodovar, et al.
Published: (2025-08-01)

CLINICAL AND PHARMACOECONOMICAL EFFICIENCY OF CEFOPERAZONE + SULBACTAM IN CHILDREN, SUFFERING FROM CYSTIC FIBROSIS
by: E.B. Pavlinova, et al.
Published: (2006-12-01)

Investigation of carbapenemase and mcr-1 genes in carbapenem-resistant Klebsiella pneumoniae isolates
by: Çiğdem Arabacı, et al.
Published: (2019-06-01)

Comparison of Antimicrobial Activity between Ceftriaxone-Sulbactam-Disodium EDTA and Ceftazidime-Avibactam against Carbapenemase Producing Enterobacterales Isolates from a Tertiary Care Hospital: An In-vitro Study
by: KV Leela, et al.
Published: (2025-08-01)

Developing a prognostic model of glutamine metabolism-related genes associated with clinical features and immune status in melanoma
by: Hongyan Hu, et al.
Published: (2025-08-01)

Glutamine Correction of Morphofunctional Disorders of the Small Bowel and Liver in the Posttraumatic Period of Experimental Cardiac Contusion (An Experimental Study)
by: V. S. Verbitskaya, et al.
Published: (2014-06-01)

Study of the effect of different diluent for Syringe Immersion Test on Rhipicephalus microplus larvae against macrocyclic lactones
by: Diego Robaina, et al.
Published: (2024-12-01)

Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases
by: Mudasir A. Kumar, et al.
Published: (2025-07-01)

Research Progress on the Preparation, Structural Analysis and Physiological Functions of Glutamine Peptides
by: LIN Lulu, ZHENG Liping, MENG Ganlu, LIU Wenying, CHEN Liang, ZHANG Xinxue
Published: (2025-07-01)

Oral low dose of glutamine improved the spontaneous closure in patients with external duodenal fistula: a retrospective comparative study with propensity score matching
by: Ming Huang, et al.
Published: (2025-07-01)

HDAC6 and USP9X Control Glutamine Metabolism by Stabilizing GS to Promote Glioblastoma Tumorigenesis
by: Go Woon Kim, et al.
Published: (2025-07-01)

Pathway metabolite ratios reveal distinctive glutamine metabolism in a subset of proliferating cells
by: Nancy T Santiappillai, et al.
Published: (2025-06-01)

CLINICAL AND PHARMACOLOGICAL APPROACHES TO OPTIMIZE THE DOSING REGIMEN OF ANTIBACTERIAL DRUGS IN PEDIATRICS
by: Natal’ya B. Lazareva, et al.
Published: (2018-04-01)

The Changing Landscape of Antibiotic Treatment: Reevaluating Treatment Length in the Age of New Agents
by: Francesca Serapide, et al.
Published: (2025-07-01)

Effects of Central Administration of Glutamine and Alanine on Feed Intake and Hypothalamic Expression of Orexigenic and Anorexigenic Neuropetides in Broiler Chicks
by: Khondowe Paul, et al.
Published: (2012-07-01)

Ablation of LAT2 Transporter Causes Intramuscular Glutamine Accumulation and Inhibition of Fasting‐Induced Proteolysis
by: Meritxell Espino‐Guarch, et al.
Published: (2025-06-01)

Carbapenem-resistant Enterobacterales bloodstream infections related to death in two Brazilian tertiary hospitals
by: Lorena Galvão de Araujo, et al.
Published: (2025-05-01)

Antibiotic Susceptibility Profile of Carbapenem Resistant Escherichia Coli and Klebsiella Pneumoniae in Urinary Isolates from a Tertiary Care Hospital: An Observational Study
by: Gaurav Verma, et al.
Published: (2025-07-01)

Disruption of glutamine transport uncouples the NUPR1 stress-adaptation program and induces prostate cancer radiosensitivity
by: Uğur Kahya, et al.
Published: (2025-07-01)

Carbapenem-resistant Pseudomonas aeruginosa T3SS virulence genes and correlation between virulence and drug resistance and molecular epidemiology studies
by: Jianhua Tang, et al.
Published: (2025-06-01)

Eliminating Assay Background of a Low-Cost, Colorimetric Glutamine Biosensor by Engineering an Alternative Formulation of Cell-Free Protein Synthesis
by: Joseph P. Talley, et al.
Published: (2025-06-01)

Molecular epidemiology and clinical characteristics of carbapenem-resistant Klebsiella pneumoniae bloodstream and pneumonia isolates
by: Phillip B. Cox, et al.
Published: (2025-08-01)

Outcomes and mortality risk scoring for infections caused by carbapenem-resistant Escherichia coli and Klebsiella pneumoniae
by: Jack El Sawda, et al.
Published: (2025-05-01)

Ceftazidime-avibactam susceptibility against Escherichia coli and Klebsiella pneumoniae
by: Arun Sachu, et al.
Published: (2025-02-01)